~~<i id='452CF7581F'><strike id='452CF7581F'><tt id='452CF7581F'><pre id='452CF7581F'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

focus

explore

author：comprehensive 2025-09-05 09:18:16 - browse：282

A green number 3 with an eye is surrounded by smaller, black number 3s on a purple background — 3 to watch coverage from STAT — Christine Kao/STAT

Life in the CRISPR lane tends to move at lightning speed. This year saw the first-ever approval of a medicine based on the gene editing technology, barely more than a decade after publication of its first demonstration by Nobel laureates Jennifer Doudna and Emmanuelle Charpentier.

The landmark decision paves the way for in vivo therapies, which edit cells inside the body, to reach patients, as well as treatments based on more efficient genome editors with fancier DNA-altering tricks up their sleeves.

Here are three CRISPR developments we’re watching in 2024:

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Supreme Court strikes down use of affirmative action
Next article： Failure, not just success, should guide future doctors

Wikipedia

leisure time

knowledge

hotspot

focus

entertainment

PauloAmorim/VWPicsviaAPImagesLONDON—EuropeanregulatorsonFridayrecommendedtheapprovalofPfizer’sRSVvac

WSS

Failure, not just success, should guide future doctors

Family of Gilgo Beach murder suspect releases statement: 'Devastating time'

Family of Gilgo Beach murder suspect releases statement: 'Devastating time'

Many breast cancer patients receive more radiation than needed

Reframing the conversation around gain

Why Marc Tessier

focus

explore

Wikipedia

23andMe had bad news about my health. I wish a person had delivered it

Listen: BridgeBio's big week & Lilly's Alzheimer's data

Novavax promises a turnaround & Lilly roils the obesity market

What is artificial intelligence? Experts weigh in

How one medical school became remarkably diverse

A fugitive mob suspect in Greece is betrayed by his passion for hometown Naples soccer champions

At least 13 dead in Texas as scorching temps continue

Prosecutors say FTX founder Sam Bankman

Wildfire smoke exposes gaps in outdoor worker protections

Family of Gilgo Beach murder suspect releases statement: 'Devastating time'

leisure time

Reframing the conversation around gain

The biotech scorecard for the 2nd quarter: 12 industry events to watch

Feed a cold, starve a fever? Here’s what science says

It's time to take a new tack for treating Alzheimer's

St. Louis police protesters begin picking up checks in $4.9 million settlement

Sweden knocks USA out of World Cup in penalty kicks

knowledge

hotspot

focus

entertainment